Specifications
- Purity
- ≥98% (GC)
- Appearance
- White crystalline powder
- Identity
- 1H-NMR
Properties
- Solvents
- chloroform, ether or methanol
Documentation
- Safety Data Sheet (SDS)
- CDX P0155 MSDS.pdf
Category: API's & Intermediates
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
A major ?-oxidation metabolite of valproic acid (VPA). Exhibits anticonvulsive potency similar to VPA and may be at least partially responsible for its neurological activity. Compound can be used as analytical reference material.
Synonyms | 2-en-VPA, Delta2-Valproic acid, 2-Propyl-2-pentenoate, 2-Propylpenten-2-oic acid |
---|---|
Purity | ≥98% (GC) |
Appearance | White crystalline powder |
CAS-Number | 60218-41-9 |
Molecular Formula | C8H14O2 |
Molecular Weight | 142.2 |
Identity | 1H-NMR |
Solvents | chloroform, ether or methanol |
Smiles | CC/C=C(CCC)/C(O)=O |
InChi Key | ZKNJEOBYOLUGKJ-FNORWQNLSA-N |
Shipping | AMBIENT |
Short Term Storage | +4°C |
Long Term Storage | -20°C |
Handling Advice | Protect from light and moisture. |
Use / Stability | Stable for at least 2 years after receipt when stored at -20°C. |
Hazard statements | H301 |
Precautionary statements | P301 + P310 |
GHS Symbol | GHS06 |
Signal word | Danger |
RIDADR | UN2811 6.1 |
Transportation | Packing Group III |
References | (1) R. Misslin, et al.: Psychopharmacol. 50, 53 (1976), (2) W. Löscher & H. Nau, J. Pharmacol. Exp. Ther. 226, 845 (1983), (3) M.J. McLean, et al.: J. Pharmacol. Exp. Ther. 237, 1001 (1986), (4) R.D. Lee, et al.: J. Pharm. Sci. 78, 667 (1989), (5) D. Hönack, et al.: Naunyn Schmiedebergs Arch. Pharmacol. 345, 187 (1992) |
InChi | InChI=1S/C8H14O2/c1-3-5-7(6-4-2)8(9)10/h5H,3-4,6H2,1-2H3,(H,9,10)/b7-5+ |
Quantity | 25 mg, 50 mg, Bulk |